CVS Health Co. (NYSE:CVS) Shares Acquired by Amundi

Amundi boosted its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 19.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,059,915 shares of the pharmacy operator's stock after purchasing an additional 1,165,992 shares during the quarter. Amundi owned about 0.56% of CVS Health worth $324,246,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health during the third quarter valued at $25,000. Legacy Investment Solutions LLC purchased a new stake in shares of CVS Health in the third quarter valued at $31,000. Ridgewood Investments LLC raised its stake in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after acquiring an additional 450 shares during the period. Stonebridge Financial Group LLC purchased a new stake in shares of CVS Health in the fourth quarter valued at $28,000. Finally, RPg Family Wealth Advisory LLC purchased a new stake in shares of CVS Health in the third quarter valued at $40,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. Argus set a $77.00 target price on shares of CVS Health in a research note on Tuesday, February 18th. Barclays increased their target price on shares of CVS Health from $71.00 to $73.00 and gave the company an "overweight" rating in a research note on Thursday, February 13th. UBS Group reduced their target price on shares of CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 11th. Leerink Partners upgraded shares of CVS Health from a "market perform" rating to an "outperform" rating and upped their price target for the stock from $55.00 to $75.00 in a report on Thursday, February 13th. Finally, Edward Jones upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a report on Thursday, January 30th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $69.83.

Remove Ads

CVS Health Stock Up 1.7 %

CVS Health stock traded up $1.09 during midday trading on Friday, hitting $66.34. 10,082,148 shares of the company's stock were exchanged, compared to its average volume of 11,965,158. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a market cap of $83.64 billion, a PE ratio of 18.12, a P/E/G ratio of 0.98 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The firm has a 50-day moving average of $56.42 and a two-hundred day moving average of $56.73.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.01%. The ex-dividend date was Thursday, January 23rd. CVS Health's dividend payout ratio is currently 72.68%.

Insider Activity

In related news, Director Michael F. Mahoney acquired 30,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The stock was purchased at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now directly owns 39,356 shares of the company's stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP James David Clark sold 7,513 shares of the stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares of the company's stock, valued at $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.24% of the company's stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.